Product information and disease descriptionProduct descriptionProduct information
Dosing and administration
2 evidence topics · 3 sources
Ulixacaltamide
Essential tremor
- Manufacturer
- Praxis Precision Medicines
- Regulatory submission
- NDA submitted by February 2026
- Launch
- Not announced
- Last updated